Peter Dubovan
Bratislava, BL, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer.
Journal: Molecular oncology
Published: July 20, 2025
Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 02, 2025
Combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells as a pancreatic ductal adenocarcinoma treatment approach.
Journal: Cancer cell international
Published: January 30, 2025
Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers.
Journal: PloS one
Published: December 20, 2024
Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications.
Journal: Seminars in cancer biology
Published: October 01, 2024
Long-Term Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction after Pancreatic Resection for Pancreatic Tumors: Single-Center Experience.
Journal: Life (Basel, Switzerland)
Published: July 14, 2024
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue.
Journal: Journal of visualized experiments : JoVE
Published: June 12, 2023
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2023
Intrathoracic liver herniation after pericardial fenestration - a case report.
Journal: Journal of cardiothoracic surgery
Published: January 03, 2023
DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines.
Journal: International journal of molecular sciences
Published: January 01, 2022
Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective.
Journal: Cancers
Published: August 03, 2021
Last Updated: 09/26/2026